Home / Conditions / Eyelid Droop

Eyelid Droop: when insurers say no, reviewers often say yes

In 45 published external-review decisions involving eyelid droop, independent physician reviewers overturned the insurer’s denial 37.8% of the time.

Published decisions
45
2001–2026
Overturned
37.8%
17 denials reversed

Most-fought treatments for eyelid droop

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Blepharoplasty33
33.3%
Typical time to a decision
21 days
Most land between 16 and 21 days
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: A patient has requested authorization and coverage for blepharoptosis repair.Based on the current medical literature, this patient’s ptosis likely represents a dehiscence of the levator aponeurosis in the right eye after surgery. The records suggest that the patient’s muscle weakened over time after the eyelid was stretched by the lid speculum during the surgery, which is essential for performing the procedure. Ptosis following eye surgery is a well-known complication. In this case, the ptosis has reportedly caused significant problems for the patient. The records indicate that the patient’s right-sided untaped visual field measured 20 degrees. The taped visual field shows an improvement of 10 degrees, eliminating the visual field defect.
Medical Necessity · 2025 · IMR MN25-43989
Nature of Statutory Criteria/Case Summary: An enrollee has requested authorization and coverage for bilateral upper lid blepharoplasties.At issue is whether bilateral upper lid blepharoplasties are medically necessary for treatment of the patient’s medical condition. Does the condition constitute an abnormal structure of the body? If so, is the abnormal structure of the body caused by any of the following: congenital effects, developmental abnormalities, trauma, infection, tumors, or disease? If so, is the requested surgery performed to do either of the following: improve function or create a normal appearance to the extent possible?
Medical Necessity · 2021 · IMR MN21-36287

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement for bilateral blepharoplasty procedures. According to the American Society of Plastic Surgeons (ASPS), blepharoplasty is recommended to correct visual impairment caused by the drooping of the eyelids (ptosis) or by excess eyelid skin (blepharochalasis). Indications for reconstructive blepharoplasty should be documented by the surgeon in the patient’s history and physical, along with formal visual field testing by an optometrist or ophthalmologist if the patient is experiencing visual impairment. A complete eye examination may also be appropriate in certain cases.
Medical Necessity · 2021 · IMR MN21-36426
Nature of Statutory Criteria/Case Summary: A patient has requested authorization and coverage for surgery to remove excess skin and tissue from the lower eyelid and raise the eyebrow position. In this case, according to the photographs, there does not appear to be significant brow ptosis and there does not appear to be appreciable lower eyelid dermatochalasis. There is a lack of support in the literature for the use of the requested procedure in such clinical scenarios. Based on the limited information provided, including the photographs, there is evidence of bilateral upper eyelid ptosis, likely due to levator aponeurosis dehiscence. However, there does not appear to be significant brow ptosis, as the brows are positioned near or above the superior orbital rim bilaterally. Additionally, there is no appreciable lower eyelid dermatochalasis noted on either side.
Medical Necessity · 2025 · IMR MN25-44494

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

How to use this in your appeal

These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for eyelid droop was denied, the published record says the denial is worth fighting.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for eyelid droop? 37.8% won.

Explain my denial — freeStart my appeal · $39